Contained evaluation of Oxitec’s solution to dengue: US and Malaysia take the lead

Friday, September 14th 2007

Oxitec achieved a major regulatory milestone in August 2007, with United States and Malaysia granting regulatory approval for contained trials of Oxitec’s RIDL Aedes aegypti mosquito strains to leading research institutions in these two countries. Oxitec’s head of public health S.S. Vasan said: “This will pave the way for independent evaluation of our promising RIDL technology to control Aedes aegypti – the [...]

Oxitec tames the tiger: Oxitec has achieved a world first by transforming the Asian tiger mosquito, an important vector of the viral disease chikungunya.

Friday, September 7th 2007

Oxitec has achieved a world first by transforming the Asian tiger mosquito (Aedes albopictus), an important vector of the viral disease chikungunya. Oxitec is developing novel technology, RIDL®, for the control of mosquitoes. Its first product, for control of the yellow fever mosquito (Aedes aegypti), which also transmits dengue fever and chikungunya, is under evaluation in [...]

Oxitec appoints Regulatory Manager

Thursday, September 6th 2007

Oxitec is pleased to announce the appointment of Camilla Beech as Regulatory Manager, with effect from 8 October.
Camilla has over twelve years’ international experience in the regulation of biotechnology products and crops. She obtained commercial food approval in the UK for the first GM crop in Europe, and obtained registrations for numerous biotechnology crops in [...]